ID   UPAR_RAT                Reviewed;         328 AA.
AC   P49616; O35771; P51573; Q7TN35;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   29-MAY-2024, entry version 144.
DE   RecName: Full=Urokinase plasminogen activator surface receptor;
DE            Short=U-PAR;
DE            Short=uPAR;
DE   AltName: CD_antigen=CD87;
DE   Flags: Precursor;
GN   Name=Plaur;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND SUBCELLULAR LOCATION.
RC   TISSUE=Osteoblast;
RX   PubMed=8307160; DOI=10.1016/0014-5793(94)80118-5;
RA   Rabbani S.A., Rajwans N., Achbarou A., Murthy K.K., Goltzman D.;
RT   "Isolation and characterization of multiple isoforms of the rat urokinase
RT   receptor in osteoblasts.";
RL   FEBS Lett. 338:69-74(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Aortic smooth muscle;
RA   DeYoung M.B., Wohlgemuth J., Dichek D.A.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=1321734; DOI=10.1016/0014-5793(92)80998-v;
RA   Ragno P., Cassano S., Degen J., Kessler C., Blasi F., Rossi G.;
RT   "The receptor for the plasminogen activator of urokinase type is up-
RT   regulated in transformed rat thyroid cells.";
RL   FEBS Lett. 306:193-198(1992).
CC   -!- FUNCTION: Acts as a receptor for urokinase plasminogen activator. Plays
CC       a role in localizing and promoting plasmin formation. Mediates the
CC       proteolysis-independent signal transduction activation effects of U-PA.
CC   -!- SUBUNIT: Monomer (Probable). Interacts (via the UPAR/Ly6 domains) with
CC       SRPX2. Interacts with MRC2 (By similarity). Interacts with SORL1 (via
CC       N-terminal ectodomain); this interaction decreases PLAUR
CC       internalization (By similarity). The ternary complex composed of PLAUR-
CC       PLAU-SERPINE1 also interacts with SORL1 (By similarity). Interacts with
CC       CD82; this interaction prevents PLAUR from binding to its high affinity
CC       ligand PLAU (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q03405, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane
CC       {ECO:0000269|PubMed:1321734}; Lipid-anchor, GPI-anchor
CC       {ECO:0000269|PubMed:1321734}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted
CC       {ECO:0000305|PubMed:8307160}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=GPI-anchored;
CC         IsoId=P49616-1; Sequence=Displayed;
CC       Name=2; Synonyms=Secreted;
CC         IsoId=P49616-3, P51573-1;
CC         Sequence=VSP_031840, VSP_031841;
CC   -!- INDUCTION: Up-regulated in transformed thyroid cell lines.
CC       {ECO:0000269|PubMed:1321734}.
CC   -!- MISCELLANEOUS: [Isoform 1]: GPI-anchored form.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA50717.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA50718.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X71898; CAA50717.1; ALT_FRAME; mRNA.
DR   EMBL; X71899; CAA50718.1; ALT_FRAME; mRNA.
DR   EMBL; X76129; CAA53732.1; -; Genomic_DNA.
DR   EMBL; AF007789; AAB62974.1; -; mRNA.
DR   EMBL; BC127499; AAI27500.1; -; mRNA.
DR   PIR; S42152; S42152.
DR   PIR; S42429; S42429.
DR   RefSeq; NP_059046.1; NM_017350.1.
DR   RefSeq; NP_599179.1; NM_134352.1. [P49616-1]
DR   AlphaFoldDB; P49616; -.
DR   SMR; P49616; -.
DR   IntAct; P49616; 1.
DR   STRING; 10116.ENSRNOP00000063960; -.
DR   BindingDB; P49616; -.
DR   ChEMBL; CHEMBL3638329; -.
DR   GlyCosmos; P49616; 7 sites, No reported glycans.
DR   GlyGen; P49616; 7 sites.
DR   PhosphoSitePlus; P49616; -.
DR   PaxDb; 10116-ENSRNOP00000063960; -.
DR   Ensembl; ENSRNOT00055056030; ENSRNOP00055046186; ENSRNOG00055032435. [P49616-1]
DR   Ensembl; ENSRNOT00060057271; ENSRNOP00060047348; ENSRNOG00060033011. [P49616-1]
DR   Ensembl; ENSRNOT00065057690; ENSRNOP00065047478; ENSRNOG00065033571. [P49616-1]
DR   GeneID; 50692; -.
DR   KEGG; rno:50692; -.
DR   AGR; RGD:620597; -.
DR   CTD; 5329; -.
DR   RGD; 620597; Plaur.
DR   eggNOG; ENOG502S36D; Eukaryota.
DR   InParanoid; P49616; -.
DR   OrthoDB; 4599852at2759; -.
DR   PhylomeDB; P49616; -.
DR   Reactome; R-RNO-162791; Attachment of GPI anchor to uPAR.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-75205; Dissolution of Fibrin Clot.
DR   PRO; PR:P49616; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098637; C:protein complex involved in cell-matrix adhesion; ISO:RGD.
DR   GO; GO:1905370; C:serine-type endopeptidase complex; ISO:RGD.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0030377; F:urokinase plasminogen activator receptor activity; TAS:RGD.
DR   GO; GO:0060742; P:epithelial cell differentiation involved in prostate gland development; IMP:RGD.
DR   GO; GO:0048762; P:mesenchymal cell differentiation; IMP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0034112; P:positive regulation of homotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISO:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEP:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd00117; LU; 3.
DR   Gene3D; 2.10.60.10; CD59; 3.
DR   InterPro; IPR018363; CD59_antigen_CS.
DR   InterPro; IPR016054; LY6_UPA_recep-like.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   PANTHER; PTHR10624:SF6; UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR; 1.
DR   PANTHER; PTHR10624; UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR-RELATED; 1.
DR   Pfam; PF00021; UPAR_LY6; 3.
DR   SMART; SM00134; LU; 3.
DR   SUPFAM; SSF57302; Snake toxin-like; 3.
DR   PROSITE; PS00983; LY6_UPAR; 3.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   GPI-anchor; Lipoprotein; Membrane; Receptor; Reference proteome; Repeat;
KW   Secreted; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..299
FT                   /note="Urokinase plasminogen activator surface receptor"
FT                   /id="PRO_0000036099"
FT   PROPEP          300..328
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000036100"
FT   DOMAIN          25..118
FT                   /note="UPAR/Ly6 1"
FT   DOMAIN          118..213
FT                   /note="UPAR/Ly6 2"
FT   DOMAIN          214..299
FT                   /note="UPAR/Ly6 3"
FT   LIPID           299
FT                   /note="GPI-anchor amidated glycine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        76
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        194
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        255
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        283
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        290
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        27..48
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        30..36
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        41..69
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        95..100
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        120..147
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        123..130
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        140..169
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        175..192
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        193..198
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        216..244
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        219..227
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        237..263
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        269..288
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   DISULFID        289..294
FT                   /evidence="ECO:0000250|UniProtKB:Q03405"
FT   VAR_SEQ         159..220
FT                   /note="SVKDEPYTKGCGSLPGCPGTAGFHSNQTFHFLKCCNFTQCNGGPVLDLQSLP
FT                   PNGFQCYSCE -> KLPAAGSPLGCPKEISKFQACKQNSHSHATAHSVPGSSESLDQLE
FT                   SDQELSYLVVSHILLSF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8307160"
FT                   /id="VSP_031840"
FT   VAR_SEQ         221..328
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8307160"
FT                   /id="VSP_031841"
FT   VARIANT         95
FT                   /note="C -> S"
FT   CONFLICT        232..234
FT                   /note="TSL -> SSF (in Ref. 1; CAA50718)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   328 AA;  35753 MW;  9CF24A90B07B2E0A CRC64;
     MGLLRRRLLL LVVVVTTCVP ASQGLRCIQC ESNQDCLVEE CALGQDLCRT TVLREWEDAE
     ELEVVTRGCA HKEKTNRTMS YRMGSVIVSL TETVCATNLC NRPRPGARGR PFPRGRYLEC
     ASCTSLDQSC ERGREQSLQC RYPTEHCIEV VTLQSTERSV KDEPYTKGCG SLPGCPGTAG
     FHSNQTFHFL KCCNFTQCNG GPVLDLQSLP PNGFQCYSCE GNSTFGCSYE ETSLIDCRGP
     MNQCLEATGL DVLGNRSYTV RGCATASWCQ GSHVADSFQT HVNLSISCCN GSGCNRPTGG
     APGPGPAHLI LIASLLLTLR LWGIPLWT
//
